Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival

Published:2021-09-03 Issue:20 Volume:12 Page:2740-2748
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Imai Hisao¹²^ORCID,Onozato Ryoichi³,Kaira Kyoichi²^ORCID,Kawashima Sayaka⁴,Masubuchi Ken¹,Nagashima Toshiteru³,Tajima Kohei³,Minato Koichi¹

Affiliation:

1. Division of Respiratory Medicine Gunma Prefectural Cancer Center Ota Japan

2. Department of Respiratory Medicine Comprehensive Cancer Center, International Medical Center, Saitama Medical University Hidaka Japan

3. Division of Thoracic Surgery Gunma Prefectural Cancer Center Ota Japan

4. Division of Pharmacy Gunma Prefectural Cancer Center Ota Gunma Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14119

Reference30 articles.

1. Cancer Statistics, 2021

2. Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

3. Survival After Recurrent Nonsmall-Cell Lung Cancer After Complete Pulmonary Resection

4. Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy

5. Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components;Cancer Medicine;2024-02

2. COMPARATIVE ANALYSIS OF MICROMETASTASIS INDICATORS AND PROGNOSIS IN FITNESS AND ATHLETIC PATIENTS WITH NON-SMALL CELL LUNG CANCER POST PULMONARY LOBECTOMY VERSUS SEGMENTECTOMY;REV INT MED CIENC AC;2023

3. Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non–small cell lung cancer;Journal of Managed Care & Specialty Pharmacy;2023-07

4. Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition;npj Precision Oncology;2023-06-08

5. Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibition;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3